The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease

Journal of Cardiac Failure

Volumn 3, Issue 4, 1997, Pages 249-254

  Kjekshus, John ^a   Pedersen, Terje R ^b   Olsson, Anders G ^b   Færgeman, Ole ^b   Pyörälä, Kalevi ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b NONE

Author keywords

Congestive heart failure; Coronary heart disease; Lipid lowering; Scandinavian Simvastatin Survival Study; Simvastatin

Indexed keywords

HYPOCHOLESTEROLEMIC AGENT; SIMVASTATIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DISEASE COURSE; HUMAN; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SURVIVAL;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; CORONARY DISEASE; DISEASE PROGRESSION; HEART FAILURE, CONGESTIVE; HUMANS; MIDDLE AGED; MULTICENTER STUDIES; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; SIMVASTATIN; SURVIVAL ANALYSIS;

EID: 0031298186     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-9164(97)90022-1     Document Type: Article

References (14)

1. CONSENSUS Trial Study Group: Effects of enalapril on mortality in severe congestive heart failure: results of the cooperative North Scandinavian Enalapril Survival Study (Consensus). N Engl J Med 1987;316:1429-1435
2. Lystash JC, Gibson RS, Watson DD, Beller GA: Early versus late congestive heart failure after initially uncomplicated anterior wall acute myocardial infarction. Am J Cardiol 1995;75:653-658
3. Brown BG, Zhao Z-A, Samo DE, Albers H: Arteriographic view of treatment to achieve regression of coronary atherosclerosis and to prevent plaque disruption and clinical cardiovascular events. Br Heart J 1993;69:848-853
4. Fuster V: Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation 1994;90:2126-2146
5. Meredith IT, Yeung AC, Weidinger FF, Anderson TJ, Uehata A, Ryan TJ, Selwyn AP, Ganz P: Role of impaired endothelium-dependent vasodilatation in ischemic manifestations of coronary artery disease. Circulation 1993; 87:V56-V66
6. Scandinavian Simvastatin Survival Study Group: Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-1389
7. Scandinavian Simvastatin Survival Study Group: Design and baseline results of the Scandinavian Simvastatin Survival Study of patients with stable angina and/or myocardial infarction. Am J Cardiol 1993;71:393-400
8. Kjekshus J, Pedersen TR, for the Scandinavian Simvastatin Survival Study Group: Reducing the risk of coronary event: evidence from 4S. Am J Cardiol 1995;76:63c-68c
9. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimar AR, MacFarlane PW, McKillop JH, Palcard CJ: Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995;333:1301-1307
10. Sacks FM, Pfeffer MA, Moye L, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warrica JW, Arnold JM, Wum CC, Davis BR, Braunwald E: The effect of pravas-tatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;335:1001-1009
11. SOLVD Investigators: Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302
12. Swedberg K, Kjekshus J: The Consensus Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (Consensus). Am J Cardiol 1988;62:60A-66A
13. Brodie BR, Stuckey TD, Kisslilng G, Hansen CJ, Weintraub RA, Kelly TA: Importance of infarct-related artery patency for recovery on left ventricular function and late survival after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 1996;228:319-325
14. Thompson GR, Hollyer J, Waters DD: Percentage change rather than plasma level of LDL-cholesterol determines therapeutic response in coronary heart disease. Curr Opin Lipidol 1995;7:6386-6388